source
- Kailera says obesity pill succeeds in late-stage trial in ChinaThe drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.BioPharma Dive · 21d ago↗ source
- STAT+: The crumbling employer-based health insurance systemToday's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance.STAT · 21d ago↗ source
- Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filingCompass Pathways said Tuesday that patients in the second of its two pivotal psilocybin trials maintained their response to treatment for at least six months, keeping the company on track to comple…